Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-23-000538
Filing Date
2023-02-08
Accepted
2023-02-08 17:14:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 laurion-pyxs123122.htm SC 13G 99624
  Complete submission text file 0001172661-23-000538.txt   101105
Mailing Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017
Business Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017 212-938-6325
Laurion Capital Management LP (Filed by) CIK: 0001390202 (see all company filings)

EIN.: 562504425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92951 | Film No.: 23600086
SIC: 2834 Pharmaceutical Preparations